Shares in Tandem Diabetes Care (NSDQ:TNDM) fell today, although the medical device maker met expectations on Wall Street with its 4th quarter results. The San Diego-based company posted losses of -$15.7 million, or -48¢ per share, on sales of $24.8 million for the 3 months ended Dec. 31, for bottom-line loss of -40% on sales loss […]
Funding Roundup
Pacira prices $300m senior notes offering
Pacira Pharmaceuticals (NSDQ:PCRX) said today that it priced $300 million of convertible 2.375% senior notes due 2022 in a private placement to qualified institutional buyers. The Parsippany, N.J.-based company also gave purchasers a 30-day option to buy an additional $45 million aggregate principal amount of notes. Get the full story at our sister site, Drug Delivery […]
Velano Vascular raises $17m for needle-free blood draw device
Velano Vascular said today that it raised $17 million from new and existing investors for its Pivo needle-free blood draw device. The San Francisco, Calif.-based company said its Pivo device is a single-use disposable product designed to collect blood from indwelling peripheral IV lines, reducing the need for needle sticks and central line access for blood collection. […]
Merit Medical backs Bluegrass Vascular’s Surfacer ‘inside-out’ catheter
Bluegrass Vascular Technologies said today that it entered a “strategic relationship” with Merit Medical (NSDQ:MMSI) for its Surfacer “inside-out” catheter that includes an equity stake and a distribution agreement. The Surfacer device is designed to provide access to the jugular vein to restore central venous access in hemodialysis patients with blocked neck veins; it won CE Mark approval […]
Contact lens maker VTI plans IPO Down Under
Visioneering Technologies this week priced its A$33.3 million initial public offering on the Australian Securities Exchange. The U.S.-based contact lens maker said it’s offering 79.4 million shares of its Class A common stock priced at ¢42 apiece. The company plans to use the net proceeds from the IPO to provide capital as VTI broadens the U.S. […]
Motus GI raises $30m for Pure-Vu colonoscopy system
Motus GI said today that it closed a $30 million private placement which it plans to use in support of the commercial launch of its Pure-Vu colonoscopy system. The lead investor in the placement was Perceptive Advisors, joined by Orchestra Medical Ventures, Ascent Biomedical Ventures, Jacobs Investment Company, GJG Life Sciences and Pura Vida Investments. The […]
Boston Scientific gets in on $45m private placement for Corindus Vascular Robotics
Boston Scientific (NYSE:BSX) got in on a $45 million private placement for Corindus Vascular Robotics (NYSE:CVRS) and the CorPath GRX device it’s developing for cardiac and peripheral vascular procedures. New investors BioStar Ventures, Consonance Capital and Hudson Executive Capital also participated, joining existing backers HealthCor Partners Management and Royal Philips (NYSE:PHG). “We are pleased to announce this financing and appreciate […]
Xenex zaps a $38m funding round for LightStrike robots
Xenex Disinfection Services said today that it raised a $38 million funding round, led by private equity shop Essex Woodlands, for its LightStrike “germ-zapping robots.” New backer Piper Jaffray Merchant Banking and existing investors Malin Corp. and Tectonic Ventures also participated, San Antonio-based Xenex said. The proceeds are earmarked for sales force growth, product development, R&D and international […]
Bristol-Myers prices $1.5B senior notes offering
Bristol-Myers Squibb (NYSE:BMY) said today that it has agreed to sell $1.5 billion of senior unsecured notes in an underwritten public offering. The offering includes $750 million in 1.6% senior notes due in 2019 and $750 million in 3.3% senior notes due in 2027, according to the New York-based company. Bristol-Myers said it plans to […]
Medrobotics confirms $20m funding round
Medrobotics, which developed the Flex robot-assisted surgery platform, today confirmed a $20 million funding round 1st reported by MassDevice.com last month. The Raynham, Mass.-based company won expanded CE Mark approval in the European Union last October for Flex for performing colorectal procedures. The system won 510(k) clearance from the FDA for transoral procedures in July 2015 (that indication […]
JDRF backs GluSense with $2m grant
GluSense said yesterday that it received a $2 million grant from the Juvenile Diabetes Research Foundation’s T1D fund for the company’s injectable glucose sensor. Israel-based GluSense, part of Rainbow Medical, is developing the Glyde continuous glucose monitor for patients with Type I diabetes. The device is injected under the skin and lasts for 1 year, […]